Literature DB >> 12352934

Potential prevention of neural tube defects by assessment of women of childbearing age through monitoring of folate.

Bhushan Kapur1, Offie Porat Soldin, Gideon Koren.   

Abstract

BACKGROUND: Three quarters of neural tube defects (NTD) can be prevented by sufficient dietary folate supplementation. Despite this knowledge, most women do not supplement their diet effectively. Red cell folate concentrations correlate with the risk of NTD, and levels of less than 900 nM are associated with an increased risk of these serious congenital anomalies.
OBJECTIVE: Laboratory tests to assess anemia include testing for folate. This study was conducted to estimate the potential benefits of informing women of reproductive age who are unaware of their low folate levels, uncovered in their anemia tests.
METHODS: The number of Ontario women of reproductive age who undergo folate tests and are at an increased risk of NTD was calculated. In addition, the authors calculated the number of NTD cases that could have been prevented if these women were informed of the possible consequences of their low folate levels should they become pregnant.
RESULTS: In 1998, red cell folate concentrations were measured in 23,109 women of childbearing age (15-45 y). Approximately half of the women [n = 11,392 (49.3%)] had folate levels below 900 nM and thus were at an increased risk of giving birth to a child with NTD should they have become pregnant. Their overall mean relative risk (RR) of NTD was 1.95, or 1:512 births. If they would have been informed of this risk and subsequently increased their consumption of folate before becoming pregnant, 22.3 cases of NTD per year could have possibly been prevented at no extra cost, since the folic acid results were a part of investigational blood tests performed for another reason (anemia).
CONCLUSIONS: Women of reproductive age who are being evaluated for the cause of anemia and have low red cell folate results constitute a high-risk group for NTD in their children. These women should be informed of the increased risk and of methods of dietary folate supplementation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12352934      PMCID: PMC3635838          DOI: 10.1097/00007691-200210000-00008

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  12 in total

1.  Fortification of foods with folic acid--how much is enough?

Authors:  J L Mills
Journal:  N Engl J Med       Date:  2000-05-11       Impact factor: 91.245

2.  Economic burden of spina bifida--United States, 1980-1990.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1989-04-21       Impact factor: 17.586

3.  Preconception counseling and women's compliance with folic acid supplementation.

Authors:  A Pastuszak; D Bhatia; B Okotore; G Koren
Journal:  Can Fam Physician       Date:  1999-09       Impact factor: 3.275

4.  Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.

Authors: 
Journal:  Lancet       Date:  1991-07-20       Impact factor: 79.321

5.  An economic appraisal of the benefits of screening for open spina bifida.

Authors:  J B Henderson
Journal:  Soc Sci Med       Date:  1982       Impact factor: 4.634

6.  The effect of folic acid fortification on plasma folate and total homocysteine concentrations.

Authors:  P F Jacques; J Selhub; A G Bostom; P W Wilson; I H Rosenberg
Journal:  N Engl J Med       Date:  1999-05-13       Impact factor: 91.245

7.  The cost of preventable conditions in adults with spina bifida.

Authors:  S L Kinsman; M C Doehring
Journal:  Eur J Pediatr Surg       Date:  1996-12       Impact factor: 2.191

8.  Folate levels and neural tube defects. Implications for prevention.

Authors:  L E Daly; P N Kirke; A Molloy; D G Weir; J M Scott
Journal:  JAMA       Date:  1995-12-06       Impact factor: 56.272

9.  Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.

Authors:  A E Czeizel; I Dudás
Journal:  N Engl J Med       Date:  1992-12-24       Impact factor: 91.245

10.  A cost-benefit analysis of prenatal diagnosis for neural tube defects selectively offered to relatives of index cases.

Authors:  A D Sadovnick; P A Baird
Journal:  Am J Med Genet       Date:  1982-05
View more
  2 in total

1.  Multivitamin supplements for pregnant women. New insights.

Authors:  Eric Ahn; Alejandro A Nava-Ocampo; Gideon Koren
Journal:  Can Fam Physician       Date:  2004-05       Impact factor: 3.275

2.  Evaluation of the levels of folate, vitamin B12, homocysteine and fluoride in the parents and the affected neonates with neural tube defect and their matched controls.

Authors:  Simmi K Ratan; Kamal Nain Rattan; Ravindra Mohan Pandey; Savita Singhal; Simmi Kharab; Manju Bala; Veena Singh; Atul Jhanwar
Journal:  Pediatr Surg Int       Date:  2008-05-08       Impact factor: 1.827

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.